🇺🇸 FDA
Pipeline program

CMP-001

CMP-001-003

Phase 1 small_molecule completed

Quick answer

CMP-001 for Non Small Cell Lung Cancer is a Phase 1 program (small_molecule) at REGENERON PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
REGENERON PHARMACEUTICALS, INC.
Indication
Non Small Cell Lung Cancer
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials